Interview 28 Oct 2022 Migraines: a new vaccine frontier beyond infectious diseases …vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the convenience and affordability of vaccines, Vaxxinity’s synthetic… October 28, 2022 - 7 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Jul 2025 14 biotech companies to know in the Boston area in 2025 …agitation in Alzheimer’s disease, with results expected in late 2025. The company is also advancing preclinical assets, including a second-generation M4 receptor modulator for schizophrenia and an NLRP3 inflammasome inhibitor… July 4, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 19 Nov 2018 Silk Biomaterial Could Regenerate the Brain After a Stroke …as Parkinson’s and Alzheimer’s, eye diseases like glaucoma and age-related macular degeneration, the repair of skin and tendons, and the treatment of incontinence and impotence caused by prostate surgery. Images… November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year …treat HER2-positive solid tumors. Last month, its autologous NK therapy was cleared by Health Canada to conduct a phase 1/2a clinical trial in people with moderate Alzheimer’s disease. ONK Therapeutics… January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2019 Update: Swedish Medical Device Fails to Treat Spinal Cord Injury …The decision was made when an interim analysis in BioArctic’s phase I/II trial concluded that the treatment was ineffective. BioArctic will instead focus on developing drugs for Alzheimer’s disease and… November 21, 2019 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 20 Apr 2020 How Has Coronavirus Affected Europe’s Biotech Stocks? …biotech stocks not related to virus research will suffer the markets’ collateral effects, for example, companies developing treatments for Alzheimer’s disease. The Swiss company GeNeuro’s stocks sank in mid-March when… April 20, 2020 - 12 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2022 Virtual trials growth leads to Cambridge Cognition acquiring eClinicalHealth …delays and costs. Many CNS disorders, such as depression and Alzheimer’s disease, are particularly suited to virtual trials as at-home daily measurements can offer richer information on the progress of… October 12, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Opinion 18 Dec 2023 What to expect from biotech clinical trials in the coming year …Alzheimer’s drug – first with the FDA approval in 2021 of Biogen’s Aduhelm (aducanumab), and of Eisai’s Leqembi (lecanemab) in 2023. Dr. Jörg-Thomas Dierks, chief executive officer (CEO) of specialist… December 18, 2023 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jul 2019 The Top 10 Biotechs You’ll Find in Lyon …targeting neurons to enhance their effect. Founded in 2013, Theranexus has three drug candidates being tested in clinical trials to treat narcolepsy, sleepiness in Parkinson’s disease, Alzheimer’s, and neuropathic pain…. July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Feb 2019 10 European Genomics Companies to Watch Out For …From this genomic information, it is identifying rare gene variants relating to a whole range of diseases ranging from Alzheimer’s to schizophrenia. Through the common ancestors shared by the majority… February 18, 2019 - 8 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Oct 2024 Six biotech companies advancing multiple sclerosis therapies …developing treatments for CNS disorders for more than 40 years, including treatments for multiple sclerosis, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, depression, lupus, and spinal muscular atrophy (SMA). With regards… October 24, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jan 2019 5 Real-Life Technologies Where Biotech Meets Science Fiction …showing high promise in complex diseases such as cancer or Alzheimer’s. Hundreds of hospitals around the world are contributing to create large databases that will help doctors make better diagnostics… January 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email